Sign in

CIK 0001824293 · <br>Emerging growth company

GRI Bio, Inc.

Sign in to watch
Ticker
GRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824369909
Phone
(619) 400-1171
Business address
2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
Former names
Vallon Pharmaceuticals, Inc.
  1. 8-K Event Executive or director change
  2. 8-K Event Other events
  3. 10-K Report Annual Report
  4. SC 13D/A Stake Beneficial Ownership Report
  5. 8-K Event Regulation FD disclosure
  6. 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Other events
  7. SC 13D Stake Beneficial Ownership Report
  8. 4 Other acquisition Director acquired 47,063 shares (other)
  9. 4 Other acquisition 10% owner acquired 47,063 shares (other)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $8.00 ($8,000)
  12. 424B4 Offering Prospectus
  13. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. EFFECT Other Notice of Effectiveness
  17. S-1MEF Other S-1MEF
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 19 of 21 · 403 filings